179 related articles for article (PubMed ID: 36153583)
1. Atorvastatin lowers serum calcium levels in lithium-users: results from a randomized controlled trial.
Soh JF; Bodenstein K; Yu OHY; Linnaranta O; Renaud S; Mahdanian A; Su CL; Mucsi I; Mulsant B; Herrmann N; Rajji T; Beaulieu S; Sekhon H; Rej S
BMC Endocr Disord; 2022 Sep; 22(1):238. PubMed ID: 36153583
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin in the treatment of Lithium-induced nephrogenic diabetes insipidus: the protocol of a randomized controlled trial.
Fotso Soh J; Torres-Platas SG; Beaulieu S; Mantere O; Platt R; Mucsi I; Saury S; Renaud S; Levinson A; Andreazza AC; Mulsant BH; Müller D; Schaffer A; Dols A; Cervantes P; Low NC; Herrmann N; Christensen BM; Trepiccione F; Rajji T; Rej S
BMC Psychiatry; 2018 Jul; 18(1):227. PubMed ID: 30012135
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, randomized, placebo-controlled pilot trial of atorvastatin for nephrogenic diabetes insipidus in lithium users.
Fotso Soh J; Beaulieu S; Trepiccione F; Linnaranta O; Torres-Platas G; Platt RW; Renaud S; Su CL; Mucsi I; D'Apolito L; Mulsant BH; Levinson A; Saury S; Müller D; Schaffer A; Dols A; Low N; Cervantes P; Christensen BM; Herrmann N; Rajji T; Rej S
Bipolar Disord; 2021 Feb; 23(1):66-75. PubMed ID: 32621644
[TBL] [Abstract][Full Text] [Related]
4. What an endocrinologist should know for patients receiving lithium therapy.
Haissaguerre M; Vantyghem MC
Ann Endocrinol (Paris); 2022 Aug; 83(4):219-225. PubMed ID: 35074396
[TBL] [Abstract][Full Text] [Related]
5. Lithium-associated hyperparathyroidism and hypercalcaemia: a case-control cross-sectional study.
Albert U; De Cori D; Aguglia A; Barbaro F; Lanfranco F; Bogetto F; Maina G
J Affect Disord; 2013 Nov; 151(2):786-790. PubMed ID: 23870428
[TBL] [Abstract][Full Text] [Related]
6. Effect of lithium on serum calcium level and parathyroid function in manic-depressive patients.
Komatsu M; Shimizu H; Tsuruta T; Kato M; Fushimi T; Inoue K; Kobayashi S; Kuroda T
Endocr J; 1995 Oct; 42(5):691-5. PubMed ID: 8574294
[TBL] [Abstract][Full Text] [Related]
7. The effect of atorvastatin on cognition and mood in bipolar disorder and unipolar depression patients: A secondary analysis of a randomized controlled trial.
Fotso Soh J; Almadani A; Beaulieu S; Rajji T; Mulsant BH; Su CL; Renaud S; Mucsi I; Torres-Platas SG; Levinson A; Schaffer A; Dols A; Cervantes P; Low N; Herrmann N; Mantere O; Rej S
J Affect Disord; 2020 Feb; 262():149-154. PubMed ID: 31733459
[TBL] [Abstract][Full Text] [Related]
8. Normalization of lithium-induced hypercalcemia and hyperparathyroidism with cinacalcet hydrochloride.
Sloand JA; Shelly MA
Am J Kidney Dis; 2006 Nov; 48(5):832-7. PubMed ID: 17060004
[TBL] [Abstract][Full Text] [Related]
9. Lithium therapy, hypercalcemia, and hyperparathyroidism.
Wolf ME; Moffat M; Mosnaim J; Dempsey S
Am J Ther; 1997; 4(9-10):323-5. PubMed ID: 10423626
[TBL] [Abstract][Full Text] [Related]
10. Reversible hypercalcemia and hyperparathyroidism associated with lithium therapy: case report and review of literature.
Khandwala HM; Van Uum S
Endocr Pract; 2006; 12(1):54-8. PubMed ID: 16524864
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.
Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC
J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539
[TBL] [Abstract][Full Text] [Related]
12. Association between lithium treatment and renal, thyroid and parathyroid function: A cohort study of 6659 patients with bipolar disorder.
Wiuff AC; Rohde C; Jensen BD; Nierenberg AA; Østergaard SD; Köhler-Forsberg O
Bipolar Disord; 2024 Feb; 26(1):71-83. PubMed ID: 37300391
[TBL] [Abstract][Full Text] [Related]
13. Endocrinopathies and renal outcomes in lithium therapy: impact of lithium toxicity.
Dineen R; Bogdanet D; Thompson D; Thompson CJ; Behan LA; McKay AP; Boran G; Wall C; Gibney J; O'Keane V; Sherlock M
QJM; 2017 Dec; 110(12):821-827. PubMed ID: 29590494
[TBL] [Abstract][Full Text] [Related]
14. [Important hypercalcaemia due to hyperparathyroidism induced by lithium].
Lions C; Precloux P; Burckard E; Soubirou JL; Escarment J
Ann Fr Anesth Reanim; 2005 Mar; 24(3):270-3. PubMed ID: 15792560
[TBL] [Abstract][Full Text] [Related]
15. Disodium pamidronate in the preoperative treatment of hypercalcemia in patients with primary hyperparathyroidism.
Jansson S; Tisell LE; Lindstedt G; Lundberg PA
Surgery; 1991 Sep; 110(3):480-6. PubMed ID: 1845370
[TBL] [Abstract][Full Text] [Related]
16. Endocrine effects of lithium: II. 'Primary' hyperparathyroidism.
Christiansen C; Baastrup PC; Lindgreen P; Transbøl I
Acta Endocrinol (Copenh); 1978 Jul; 88(3):528-34. PubMed ID: 581022
[TBL] [Abstract][Full Text] [Related]
17. Lithium, hypercalcemia, and hyperparathyroidism.
Herman SP
Biol Psychiatry; 1981 Jun; 16(6):593-5. PubMed ID: 7260220
[No Abstract] [Full Text] [Related]
18. Increased prevalence of primary hyperparathyroidism in treated breast cancer.
Fierabracci P; Pinchera A; Miccoli P; Conte PF; Vignali E; Zaccagnini M; Marcocci C; Giani C
J Endocrinol Invest; 2001 May; 24(5):315-20. PubMed ID: 11407650
[TBL] [Abstract][Full Text] [Related]
19. Hypercalcemia and diabetes insipidus in a patient previously treated with lithium.
Khairallah W; Fawaz A; Brown EM; El-Hajj Fuleihan G
Nat Clin Pract Nephrol; 2007 Jul; 3(7):397-404. PubMed ID: 17592473
[TBL] [Abstract][Full Text] [Related]
20. Lithium stimulates the release of human parathyroid hormone in vitro.
Birnbaum J; Klandorf H; Giuliano A; Van Herle A
J Clin Endocrinol Metab; 1988 Jun; 66(6):1187-91. PubMed ID: 3372682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
